Upgrade to SI Premium - Free Trial

TD Cowen on Edwards Lifesciences (EW): 'TAVR to Drive Results with Room for Upside'

July 21, 2026 8:18 AM
TD Cowen analyst Joshua Jennings reiterated a Buy rating and $104.00 price target on Edwards Lifesciences (NYSE: EW).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments